3D-Darstellung des terminalen Bronchialbaums

submitted by: habi

Vortrag über meine Arbeit der letzten Monate am Tag der Anatomie 2008
Talk about my recent work at the "Tag der Anatomie 2008", an inhouse talk-session.

First-year progress in MD Anderson’s Moon Shots Program

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 announced its Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. The program initially targets acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS); chronic lymphocytic leukemia (CLL); lung cancer; melanoma; prostate cancer; and triple-negative breast and high-grade serious ovarian cancers....

Firing up innate immunity to stop asthma attacks

submitted by: mdanderson
The National Institutes of Health will provide $2.4 million to an MD Anderson researcher to advance a completely new approach to stifling asthma attacks. Scott Evans, M.D., of MD Anderson's Department of Pulmonary Medicine, was named an NIH New Innovator for his proposal to jump-start a rapid immune response to stymie viral infections before they can provoke asthma attacks. "Asthma affects 8 percent of Americans -- 26 million adults and children -- and its incidence continues to grow for...

New Lung Cancer Screening Offered At MD Anderson

submitted by: mdanderson

Results from national clinical trial mobilizes a team of experts to develop Lung Cancer Screening Program. For appointment contact AskMDAnderson 877-MDA-6789 https://www2.mdanderson.org/sapp/contact/selfreferral/index.cfm

UT MD Anderson Cancer Center launches unprecedented Moon Shots Program to increase patient survival during the next decade

submitted by: mdanderson
Inspired by America’s drive a generation ago to put a man on the moon, MD Anderson’s Moon Shots Program is a highly-concentrated effort to rapidly and dramatically decrease suffering and death in several major cancers, including acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS); chronic lymphocytic leukemia (CLL); lung; melanoma; prostate and two cancers linked at the molecular level: triple-negative breast and ovarian. Focused teams are building on new technology and...

Forest Rohwer: Microbes of the ocean, coral reefs and the human lung (MWV63)

submitted by: MicrobeWorld
In episode 63 of MicrobeWorld Video, Dr. Stan Maloy talks with Forest Rohwer Ph.D., Professor of Biology, San Diego State University, about his research on the microbes of the ocean, coral reefs and the human lung. This episode was filmed at the American Association for the Advancement of Science Meeting in Vancouver, Canada on February 18th, 2012. Viruses make up a large portion of the world's oceans, with over ten million per milliliter of seawater. Rohwer's interest in better...

Stereotactic body radiation therapy cancer treatment

submitted by: mdanderson
Stereotactic body radiation therapy (SBRT) differs from traditional radiation therapy for cancer patients. Treatment takes less time (four days versus seven weeks), it’s double the radiation dose and it spares the healthy tissue surrounding the tumor. SBRT is commonly used to treat lung and pancreatic cancers, as well as cancers that have spread to the liver, lung, adrenal glands and spine. Joe Chang, M.D., Ph.D., associate professor in Radiation Oncology at MD Anderson Cancer Center,...

Cancer Research for Stage 1 Lung Cancer

submitted by: mdanderson

New cancer research for stage 1 lung cancer is being investigated at The University of Texas MD Anderson Cancer Center. It’s led by Jack Roth, M.D., professor in the Department of Thoracic and Cardiovascular Surgery. This clinical trial called STARS (Stereotactic Radiation Therapy Verses Surgery) compares a new type of radiation treatment with a traditional surgery approach. Roth describes this promising new treatment and explains how lung cancer patients may get involved.